Home | Contact Us 

Online Catalog

View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at

How Can We Help You?
Click here to contact us!


Sepragen Corporation Announces The Addition Of Joseph R. Mallon, Jr. To Its Board Of Directors

Union City, CA, February 7, 2000 - Sepragen Corporation (OTC BB: SPGNU, SPGNA, SPGNW) today announced the appointment of Joseph R. Mallon, Jr. to its Board of Directors. Mr. Mallon is Chairman and CEO of Measurement Specialties, Inc. (AMEX:MSS).

Vinit Saxena, Chairman and CEO of Sepragen Corporation stated “Joe Mallon’s operational success at Measurement Specialties will be invaluable to Sepragen as we transition from the development of our patented applications to maximizing the substantial commercial opportunities for our products in the marketplace.”

Mr. Mallon became CEO of Measurement Specialties in 1995 after serving as a member of its board. Under Mr. Mallon’s leadership, Measurement Specialties’ revenues have tripled and earnings have increased ten fold. Mr. Mallon is a recognized pioneer in the area of silicon micromaching and has been awarded 40 U.S. patents and has published more than 50 papers.

“I am pleased to be joining the board of Sepragen Corporation.” said Mr. Mallon, he added, “Sepragen is poised with the technology and people to move from an extended entrepreneurial phase to significant growth.As a shareholder and Board member, I am excited with the prospect of working with management to help in this time of exciting potential growth.”

Sepragen Corporation develops and markets technology along with equipment and supplies for process chromatography applications. Sepragen has developed a number of patented applications that provide large market opportunities in the food and beverage industry, including debittering citrus juices, extracting isoflavone (plant estrogen) from soy, as well as extracting proteins from whey. The company holds over 14 issued patents relating to its core technology.

Return to News Archives main page

The statements in this release that relate to future events or performance, statements about growth, future regulatory clearances, levels of sales and market size and future manufacturing capacity and efficiencies are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to the development of markets for and commercial acceptance of the company's products and services, the availability of components, competitors' product introductions and other risks identified in the company's SEC filings. Actual results may differ from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2020 Sepragen Corporation. All rights reserved. (510) 475-0650